Market revenue in 2020 | USD 1,103.5 million |
Market revenue in 2028 | USD 1,255.4 million |
Growth rate | 1.6% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.68% in 2024. Horizon Databook has segmented the Germany infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the key markets for infectious respiratory disease diagnostics in Europe. Key manufacturers, such as F. Hoffmann La Roche Ltd. and Bio-Rad Laboratories, Inc., are targeting Germany due to its potential for growth in the respiratory disease diagnostics market.
For instance, in March 2020, Bayer AG is provided more than 40 diagnostic devices in various sites across Germany to increase the country’s COVID19 testing capacity. Moreover, Robert Bosch GmbH developed a rapid COVID-19 test that diagnoses nine other respiratory diseases with a turn around time of 2.5 hours.
The country has been significantly impacted by the SARS-CoV-2 pandemic, and the increasing demand for testing is driving the sales of diagnostics for respiratory diseases. In March 2021, post the detection of 1 million cases in a week in Europe, the German supermarkets have rolled out seven approved home-test kits costing USD 30.47 for five antigen test kits.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Germany infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account